AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bdaxit 1mg Tablet

Prescription Icon
Prescription Required

Marketer

BDR Pharmaceuticals Internationals Pvt

Salt Composition

Axitinib (1mg)

Overview Bdaxit 1mg Tablet

Oncaspar 1mg tablets are prescribed for kidney cancer treatment. This anti-cancer medication can be ingested with or without food, but consistent daily timing maximizes efficacy. Dosage and frequency are determined by your physician based on your individual needs and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdosing can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under your doctor's guidance. Common side effects include hypertension, arthralgia, and anorexia. While diarrhea and dyspnea can sometimes be severe, manage these with prescribed medication or increased hydration. Regular blood pressure monitoring may be advised. Report severe headache, disorientation, visual disturbances, nausea, or vomiting to your doctor immediately. Prior to commencing treatment, disclose any thyroid issues, hepatic impairment, bleeding disorders, or concurrent use of antimicrobial medications. Interaction with other drugs is possible; inform your healthcare provider of all medications you are taking. This medication is contraindicated during pregnancy and lactation. Women of childbearing age should utilize effective contraception throughout treatment.

Primary Ingredients of Bdaxit 1mg Tablet

The information is unavailable.

Uses of Bdaxit 1mg Tablet

Renal cell carcinoma

Major Benefits of Bdaxit 1mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Bdaxit 1mg Tablet can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Bdaxit 1mg Tablet:

  • High blood pressure
  • Joint pain
  • Loss of appetite
  • Diarrhea
  • Breathing problems
  • Abdominal pain
  • Constipation
  • Cough
  • Decreased appetite
  • Decreased level of thyroid hormones
  • Difficulty in speaking
  • Dry skin
  • Indigestion
  • Headache
  • Nausea
  • Pain in extremities
  • Painful blisters on hands and feet
  • Protein in urine
  • Rash
  • Breathlessness
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Vomiting

How to use Bdaxit 1mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Bdaxit 1mg Tablet can be consumed with or without food, although consistent timing is recommended.

How Bdaxit 1mg Tablet works:

Oncasin 1mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for triggering cancerous cell proliferation, thereby curbing or retarding tumor growth.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Bdaxit 1mg Tablet lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Bdaxit 1mg tablets during pregnancy carries a confirmed risk to the fetus and is therefore inadvisable. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the known hazards. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Bdaxit 1mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking a Bdaxit 1mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Bdaxit 1mg tablets pose no safety concerns for patients with kidney impairment; no dosage modification is necessary.

LiverLiverCAUTION

Exercise caution when administering Bdaxit 1mg Tablet to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Data regarding Bdaxit 1mg Tablet use in patients exhibiting severe liver dysfunction is currently limited.

What if you forget to take Bdaxit 1mg Tablet :

NA

Facts to Know About Bdaxit 1mg Tablet

LabelValue
Type of Compound Enzamide-based medication and an indazole derivative compound.
Potential for Dependence None.
Type of Medication Cancer treatments
Mechanism of Action Kinase inhibitors targeting tyrosine

FAQs on Bdaxit 1mg Tablet

Kidney cancer can manifest with various indicators, including the presence of blood in urine (hematuria), potentially exhibiting a dark red, orange, or pink discoloration. Advanced stages of the disease may be accompanied by ongoing pain, discomfort beneath the ribs, or overwhelming tiredness.
Treatment length differs individually. Your physician will determine the treatment period according to your health status, response to therapy, and tolerability of any adverse reactions. They might reduce your dosage or halt treatment—either temporarily or permanently—should side effects occur.
Seek immediate medical attention if you experience an allergic reaction, indicated by symptoms like a rash, hives, itching, or blisters. Inform your physician if you observe bleeding or blood in your sputum, significantly elevated blood pressure, or signs of thyroid dysfunction including weight fluctuations, anxiety, agitation, fatigue, or hair loss following Bdaxit 1mg Tablet administration. Similarly, report abrupt mood shifts, tachycardia, vocal changes, fever, or chills to your doctor promptly.
Prior to commencing this medication, your physician might recommend various diagnostic assessments, including blood pressure measurement, thyroid, kidney, liver, and pancreatic function evaluations, complete blood cell counts, urinalysis, and blood electrolyte analysis (sodium and potassium levels). Pregnant or potentially pregnant women should undergo a pregnancy test before initiating treatment.
Individuals with an allergy to axitinib or any Bdaxit 1mg Tablet component should avoid its use. Consult your physician if you have any uncertainty.
This medication carries a potential risk of impacting fertility in both men and women. Consult your physician prior to commencing treatment to discuss fertility preservation options.
Feeling unusually tired or fatigued is a frequent occurrence among patients using Bdaxit 1mg Tablet. Managing this tiredness may require scheduling adjustments. Prioritize sufficient rest and avoid strenuous physical exertion. Light exercise, like walking, can be beneficial in combating fatigue.
Thyroid function should be checked regularly before and throughout your Bdaxit 1mg Tablet treatment. Your physician will order blood tests to evaluate this. Report any symptoms like unusual fatigue, weight fluctuations, altered temperature sensitivity, hair thinning, vocal changes (including a lower voice), muscle spasms, or pain.
Rare but severe neurological side effects, including Reversible Posterior Leukoencephalopathy Syndrome (RPLS), have been linked to Bdaxit 1mg Tablet. RPLS manifests as headaches, visual disturbances, cognitive impairment, seizures, hypertension, weakness, and cerebral edema. This condition is treatable and symptoms typically improve with appropriate intervention. Seek immediate medical attention if you experience these symptoms while using Inlyta tablets.
Using Bdaxit 1mg Tablet carries a heightened risk of heart failure. Symptoms like unusual fatigue, abdominal, leg, or ankle swelling, breathlessness, and distended neck veins may occur. These are serious indicators of potential heart failure and require immediate medical attention. Report any of these side effects to your physician promptly.
Keep the medication in a cool, dry area, inaccessible to children and animals, to prevent unintentional ingestion.
Bdaxit 1mg Tablet
369
MRP 450
18% off